CN103267856A - Application of kit for diagnosing jaw cancer - Google Patents

Application of kit for diagnosing jaw cancer Download PDF

Info

Publication number
CN103267856A
CN103267856A CN2013101908457A CN201310190845A CN103267856A CN 103267856 A CN103267856 A CN 103267856A CN 2013101908457 A CN2013101908457 A CN 2013101908457A CN 201310190845 A CN201310190845 A CN 201310190845A CN 103267856 A CN103267856 A CN 103267856A
Authority
CN
China
Prior art keywords
saliva
test paper
jaw
crisp1
rich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101908457A
Other languages
Chinese (zh)
Other versions
CN103267856B (en
Inventor
朱进安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Tenth Peoples Hospital
Original Assignee
SUZHOU MAERTAI NEW MATERIAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU MAERTAI NEW MATERIAL CO Ltd filed Critical SUZHOU MAERTAI NEW MATERIAL CO Ltd
Priority to CN201310190845.7A priority Critical patent/CN103267856B/en
Publication of CN103267856A publication Critical patent/CN103267856A/en
Application granted granted Critical
Publication of CN103267856B publication Critical patent/CN103267856B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to application of CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing jaw cancer in preparation of medical appliances for diagnosing jaw cancer. The test paper comprises a substrate, a sample pad, a colloidal gold pad, a nitrocellulose membranous layer and a water-absorption paper layer, wherein the nitrocellulose membranous layer contains a BSA (bovine serum albumin)-saliva CRISP1 coupling substance test line and an anti-mouse secondary antibody quality control line; and the colloidal gold pad contains a colloidal gold labeled anti-saliva CRISP1 antibody compound formed by combining colloidal gold and anti-saliva CRISP1 antibody. The test paper provided by the invention has the advantages of high detection speed, high sensitivity, high specificity, high stability, no need of any instrument or equipment, and visual and reliable judgment result, is simple to operate and easy to master, and is convenient for patients to perform self-monitoring of the state of illness.

Description

A kind of application of diagnosing the carcinoma of jaw kit
Technical field
The present invention relates to diagnose the application of carcinoma of jaw kit.
Background technology
Carcinoma of jaw is that the malignant tumour of oromaxillo-facial region is the most common with cancer, in the cancer knurl again with squamous cell carcinoma for seeing at most.In China, the multiple 40-60 that is born in of oromaxillo-facial region squama cancer is between year, the male sex is more than the women, with gingival carcinoma, tongue cancer, the cheek cancer, palate cancer and carcinoma of maxillary sinus are common, carcinoma of jaw is then more rare relatively, carcinoma of mouth is to the north of China the Changjiang river, account for the 1.45-5.6% of whole body malignant tumour, be 1.75-5.18% on the south the Changjiang river India its in the whole body malignant tumour up to more than 40%, carcinoma of jaw mainly betides the remaining cell that tooth bud becomes the glaze epithelium, these epithelial cells can remain in parodontium, tumour lining and cancerate from the enamel cell knurl, it can be also gland epithelioma of squama cancer on histological type.
Summary of the invention
The objective of the invention is at deficiency of the prior art, provide a kind of diagnose carcinoma of jaw be rich in the application of halfcystine secretory protein 1 test paper in the medicine equipment of preparation diagnosis carcinoma of jaw.
For achieving the above object, the technical scheme that the present invention takes is: a kind of diagnose carcinoma of jaw be rich in the application of halfcystine secretory protein 1 test paper in the medicine equipment of preparation diagnosis carcinoma of jaw, described test paper, comprise base plate, sample pad, the gold size pad, cellulose nitrate rete and absorbent paper layer, cover sample pad on the described base plate successively, the gold size pad, cellulose nitrate rete and absorbent paper layer, contain bovine serum albumin(BSA)-saliva on the described cellulose nitrate rete and be rich in the p-wire of halfcystine secretory protein 1 conjugate and the nature controlling line that anti-mouse two resists, containing collaurum and anti-saliva on the described gold size pad is rich in halfcystine secretory protein 1 antibody and is combined the gold that forms and marks anti-saliva and be rich in halfcystine secretory protein 1 antibody complex, the diagnosis sample of described test paper is saliva, and the detection fault value of described test paper is that saliva is rich in halfcystine secretory protein 1 concentration 10-40ng/ml.
The invention has the advantages that: the new purposes that is rich in halfcystine secretory protein 1 is provided, provide convenience for the oneself of the large-scale crowd examination of carcinoma of jaw, carcinoma of jaw postoperative patient detects, reliably, do not have wound, inexpensive method, instruct the treatment of carcinoma of jaw; Detection paper of the present invention is quick, highly sensitive, high specificity, good stability, easy and simple to handle, need not any instrument and equipment, and the result judge intuitive and reliable, be easy to grasp, also make things convenient for patient to state of an illness self-monitoring simultaneously.
Description of drawings
Accompanying drawing 1 is the structural representation of the CRISP1 diagnose test paper of carcinoma of jaw.
Accompanying drawing 2 is testing result synoptic diagram of the CRISP1 diagnose test paper of carcinoma of jaw.
Accompanying drawing 3 is testing process synoptic diagram of the CRISP1 diagnose test paper of carcinoma of jaw.
Embodiment
Below embodiment provided by the invention is elaborated.
Embodiment 1
Below in conjunction with accompanying drawing embodiment provided by the invention is elaborated.
The Reference numeral and the ingredient that relate in the accompanying drawing are as follows:
1. base plate 2. sample pad
3. gold size pad 4. cellulose nitrate retes
5. absorbent paper layer 6. salivas
7. chromatography direction
Embodiment 1 SABC
Experiment material: normal mandibular organization, carcinoma of jaw tissue; Primary antibodie is goat-anti people CRISP1 antibody, the anti-sheep Dylight594 of two anti-donkeys antibody.
Experimental technique:
Organization chip is combined in a large amount of tissue samples a small substrate surface exactly in an orderly manner, detects by immunohistochemical method.
1, will organize with the PFA immobile liquid and fix 5 minutes, PBS washed 10 minutes
2, antigen retrieval: expose antigen with the 0.01M citrate solution and determine family.The heating in 3 minutes of the high fire of micro-wave oven is repaired liquid to boiling (4 minutes), and continuously low fiery microwave is 1 minute, twice again.Be cooled to room temperature, PBS washed 10 minutes.Triton rupture of membranes with 0.5% 10 minutes.
3, sealing nonspecific proteins
1) PBS soaks 3 minutes * 3 times
2) 3% H 2O 2-methyl alcohol (30% H 2O 210ml+ methyl alcohol 90ml) soaking at room temperature is 30 minutes
3) the tap water flushing is 10 minutes, and PBS soaks 3 minutes * 3 times, and drying or paper handkerchief are inhaled and removed unnecessary liquid (not running into tissue), draws circle (distilled water flushing prepares 10% and seals serum in the time) with the groupization pen around tissue
4) splashing into 5% BSA(rapidly in circle inner tissue prepares with PBS), sealing heterogenetic antigen (do not allow tissue dry, should after paper handkerchief sops up water, add immediately), room temperature 30 minutes (preparing primary antibodie) is deducted confining liquid, does not wash.
4, primary antibodie is hatched
Get rid of the BSA on cutting into slices, dry tissue residual BSA on every side with filter paper, the goat-anti people CRISP1 antibody (about 60 μ l) that direct adding has been diluted is put into wet box and is spent the night for 4 ℃.From refrigerator, took out in second day and need 37 ℃ of rewarming 30 min.
5, two anti-hatching
1) primary antibodie is washed off, slide is inserted the plastic slide frame, the whole plastic casing of putting into then adds PBS and soaks to be put in and wash 10 minutes on the microoscillator.
2) with filter paper the suction of the water around the circle is gone, add the anti-sheep Dylight594 of two anti-donkeys antibody, room temperature 30 minutes.
3) adding PBS soaks to be put in and washes 10 minutes on the microoscillator.
6, mounting
Paper handkerchief is absorbed unnecessary liquid, and dropper drips one of DAPI mounting liquid on slide, and covered is pushed gently with tweezers then, and drives bubble away, and room temperature was placed 1 hour.Observe.
Experimental result, organization chip immunohistochemical staining show that the CRISP1 secretory protein is the obvious positive in 23 of 30 carcinoma of jaw tissues, and negative in normal structure.
Embodiment 2 enzyme-linked immunosorbent assays (Elisa)
Totally totally 90 examples, wherein carcinoma of jaw (squamous cell carcinoma) case group 30 examples; Oral cavity other diseases (periodontosis, dental pulp disease, thrush) group 30 examples; Normal healthy controls crowd's 30 examples.Employing is rich in halfcystine secretory protein detection kit and is detected, and detects step with reference to being rich in the quantitative elisa kit for detecting operation instructions of halfcystine secretory protein.
The ELISA testing result of CRISP1:
1. the carcinoma of jaw group is higher than other two groups, and other diseases group and healthy population group indifference (P=0.802).
The diagnostic value of table 1 saliva CRISP1 diagnosis carcinoma of jaw
Diagnosis index AUC Sensitivity Specificity False positive rate False negative rate The Youden index
Urine CRISP1 10 ng/ml 0.823 89.1% 38.3% 58.5% 13.8% 0.274
Urine CRISP1 40 ng/ml 0.823 76.4% 89.6% 12.8% 27.5% 0.660
(illustrate: AUC:ROC curve (experimenter's performance curve) is area down; AUC illustrates that more close to 1 diagnosis effect is more good; AUC had low accuracy at 0.5~0.7 o'clock, AUC had certain accuracy at 0.7~0.9 o'clock, and AUC has high accuracy when above 0.9.Youden index: youden index=sensitivity+specificity-1; It is the excellent diagnostics dividing value that the Youden index reaches maximum corresponding value.)
The diagnostic value height of the carcinoma of jaw of saliva CRISP1, its AUC reaches 0.823.Be diagnostic threshold with CRISP1 10ng/ml, its diagnostic sensitivity to carcinoma of jaw is 89.1%, and specificity is 38.3%, and false positive rate is 58.5%, and false negative rate is 13.8%; Be diagnostic threshold with CRISP1 40 ng/ml, its sensitivity is 76.4%, and specificity is 89.6%, and false positive rate is 12.8%, and false negative rate is 27.5%.Saliva CRISP1 concentration 40 ng/ml are the excellent diagnostics dividing value; Saliva CRISP1 concentration 10 ng/ml can be used for the screening purpose.
The golden labeling antibody compound of embodiment 3 preparation test paper
One, Preparation of Colloidal Gold
Be heated to boiling in the chlorauric acid solution adding round-bottomed flask with 100ml 0.005%-0.02%, the boiling back adds the trisodium citrate (Na of freshly prepared 0.4%-2% quickly and accurately under vigorous stirring 3C 6H 5O 72H 2O) aqueous solution 1-2.2ml, boil 10-25 minute after, continue to stir and to be cooled to room temperature.The change color that can see solution in this process is: golden yellow → black → purple → dark blue → cerise when the color of solution becomes transparent cerise fully, namely makes required collaurum.Pack into after the cooling in the bag filter to ultrapure water (1:5000) dialysis three times, the collaurum of getting well of will dialyse is at last transferred in the vial of clean band spiral cover, preserves under the environment of 4 ℃ of lucifuges.
Two, gold colloid and albumen is connected
1, collaurum depends primarily on the pH value to the absorption of albumen, and near the isoelectric point of protein or partially under the condition of alkali, the two forms firm bond easily.When if the pH value of collaurum is lower than the isoelectric point of protein, then can assembles and lose binding ability.
2, the preparation of protein solution to be marked: with albumen to be marked 4 ℃ of dialysed overnight in 0.003 mol/l-0.01 mol/l pH5.5-7.8 NaCl solution in advance, to remove unnecessary salt ion.100000 change 4 ℃ of centrifugal 1h then, remove polymkeric substance.
3, wait to mark the preparation of colloidal gold solution: with 0.05 mol/l-0.3 mol/l K 2CO 3Transferring the pH value of collaurum liquid is 7.5-10.0.Because colloidal gold solution may damage the electroplax of pH meter, therefore, when regulating pH, adopt accurate pH test paper to be determined as suitable.
4, determining of the ratio of collaurum and labelled protein consumption: according to the requirement of albumen to be marked, collaurum is mixed up after the pH packing 10 pipes, every pipe 1ml.It is 5 μ g/ml~50 μ g/ml that labelled protein is done serial dilution with 0.005mol/l pH9.0 borate buffer solution, gets 1ml respectively, adds in the above-mentioned gold size solution mixing.Control tube only adds the 1ml dilution.Behind the 5min, in above-mentioned each pipe, add 0.1ml 10%NaCl solution, leave standstill 2h behind the mixing, observations.The quantity not sufficient of control tube (not adding protein) and adding protein all presents the coagulation phenomenon by red stain indigo plant with each pipe of stable colloid gold; Still maintenance is red constant and the adding protein content meets or exceeds each quantitative pipe of minimum steady.Stablize the red constant minimum protein consumption of 1ml colloidal gold solution, be the minimum amount of this protein of mark, in real work, can suitably increase by 10%~20%.
5, the combination of collaurum and anti-CRISP1 monoclonal antibody: with colloidal gold solution with 0.05 mol/l-0.3 mol/l K 2CO 3Transfer pH to 7.5-10.0, add the good anti-CRISP1 monoclonal antibody solution of dialysis, the eddy mixer mixing behind the reaction 10min, adds stabilizing agent and precipitates to prevent the collaurum polymerization.Stabilizing agent commonly used is 5% hyclone (BSA) and 1% polyglycol (molecular weight 20KD).The amount that adds: it is 1% that 5%BSA makes the solution final concentration; 1% polyglycol adds to 1/10 of total solution.
6, the purifying of colloid gold label albumen: the colloid gold label antibody complex for preparing is at the centrifugal 15min of 900rpm/min, careful sucking-off supernatant, and sediment redissolves with containing 5% sucrose and the 0.002M borate buffer solution of 0.05% Tween-20.Centrifuge washing twice is concentrated into compound 1/10,4 ℃ of preservation of original volume at last.
The CRISP1 test paper of embodiment 4 preparation quick diagnosis carcinoma of jaw
Please refer to accompanying drawing 1, accompanying drawing 1 is the structural representation of the CRISP1 diagnose test paper of carcinoma of jaw.This test paper is provided with base plate 1, covers sample pad 2, gold size pad 3, cellulose nitrate rete 4 and absorbent paper layer 5 on the base plate successively.Described base plate 1 is the PVC base plate, and the material of sample pad 2 is to inhale the saliva glass fibre.The making of gold size pad 3: on the wide glass fibre membrane of 1cm, the point sample amount is about 2ul/cm, 37 ℃ of dryings with embodiment 3 preparation-obtained golden labeling antibody solution speckings.The making of cellulose nitrate rete 4: with two anti-speckings on nitrocellulose membrane (NC film), as nature controlling line (C line).To resist CRISP1 polyclonal antibody specking at distance nature controlling line 1cm place as p-wire (T line), the point sample amount is about 1ul/cm.The detection threshold of described p-wire (T line) is 10-40 ng/ml.37 ℃ of dryings.Above-mentioned sample pad, gold size pad, cellulose nitrate rete, absorbent paper layer are assembled on the base plate successively, are cut into the wide test strips of 4mm, in the test card of packing into.
The detection of the CRISP1 test paper of embodiment 5 quick diagnosis carcinoma of jaw
Please refer to accompanying drawing 2, accompanying drawing 2 is testing result synoptic diagram of the CRISP1 diagnose test paper of carcinoma of jaw.
One, test paper detecting method:
1, the sample to be tested (saliva) of getting 50ul is added in the sample application zone S place of test strips;
2, in 10min postscript observed and recorded testing result.The result who observes behind the 20min is invalid.
Two, the judgement of testing result:
1, positive findings: please refer to accompanying drawing 2A, on the p-wire T line of test strips and nature controlling line C line position, an aubergine band respectively occurs.
2, negative findings: please refer to accompanying drawing 2B, only an aubergine band occurs at the nature controlling line C of test strips line.
3, null result: please refer to accompanying drawing 2C, on the nature controlling line C of test strips line, the aubergine band do not occur.
Three, detect principle
Please refer to accompanying drawing 3, accompanying drawing 3 is testing process synoptic diagram of the CRISP1 diagnose test paper of carcinoma of jaw.As shown in the figure, several salivas 6 drop on the sample pad 2, because of the chromatography effect, 5 directions flow liquid along chromatography direction 7 to absorbent paper layer, when flowing through gold size pad 3, the gold labeling antibody just can be dissolved, and the CRISP1 in saliva is combined, form gold mark compound, continue reach with liquid, when flowing through T line (detection line), the anti-CRISP1 polyclonal antibody of compound on the T line is combined and condensed colour developing, when flowing through C line (nature controlling line), compound and two resistive connections close and condense colour developing, and not developing the color as the C line shows that then detection is invalid.If the colour developing of T line shows that then CRISP1 content is more than or equal to 10-40ng/ml in patient's saliva, positive, expression has the possibility of suffering from carcinoma of jaw, if the T line does not develop the color and shows that then CRISP1 content is normal in patient's saliva.

Claims (1)

  1. One kind diagnose carcinoma of jaw be rich in the application of halfcystine secretory protein 1 test paper in the medicine equipment of preparation diagnosis carcinoma of jaw, described test paper, comprise base plate, sample pad, the gold size pad, cellulose nitrate rete and absorbent paper layer, cover sample pad on the described base plate successively, the gold size pad, cellulose nitrate rete and absorbent paper layer, contain bovine serum albumin(BSA)-saliva on the described cellulose nitrate rete and be rich in the p-wire of halfcystine secretory protein 1 conjugate and the nature controlling line that anti-mouse two resists, containing collaurum and anti-saliva on the described gold size pad is rich in halfcystine secretory protein 1 antibody and is combined the gold that forms and marks anti-saliva and be rich in halfcystine secretory protein 1 antibody complex, the diagnosis sample of described test paper is saliva, and the detection fault value of described test paper is that saliva is rich in halfcystine secretory protein 1 concentration 10-40ng/ml.
CN201310190845.7A 2013-05-22 2013-05-22 Application of kit for diagnosing jaw cancer Expired - Fee Related CN103267856B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310190845.7A CN103267856B (en) 2013-05-22 2013-05-22 Application of kit for diagnosing jaw cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310190845.7A CN103267856B (en) 2013-05-22 2013-05-22 Application of kit for diagnosing jaw cancer

Publications (2)

Publication Number Publication Date
CN103267856A true CN103267856A (en) 2013-08-28
CN103267856B CN103267856B (en) 2015-04-29

Family

ID=49011495

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310190845.7A Expired - Fee Related CN103267856B (en) 2013-05-22 2013-05-22 Application of kit for diagnosing jaw cancer

Country Status (1)

Country Link
CN (1) CN103267856B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027178A1 (en) * 2001-03-16 2003-02-06 George Vasmatzis Methods and kits for determining a cancer diagnosis and prognosis
WO2007092713A2 (en) * 2006-02-02 2007-08-16 Trustees Of The University Of Pennsylvania Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
CA2693546A1 (en) * 2009-11-03 2011-05-03 Universite Laval Detection of human cysteine-rich secretory protein (crisp1) in semen and medical applications related thereto
CN102914658A (en) * 2012-10-24 2013-02-06 高维强 Application of CRISP3 protein on diagnosis and treatment of prostate cancer
WO2013070089A1 (en) * 2011-11-08 2013-05-16 Caldera Health Limited Method and materials for the diagnosis of prostate cancers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027178A1 (en) * 2001-03-16 2003-02-06 George Vasmatzis Methods and kits for determining a cancer diagnosis and prognosis
WO2007092713A2 (en) * 2006-02-02 2007-08-16 Trustees Of The University Of Pennsylvania Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
CA2693546A1 (en) * 2009-11-03 2011-05-03 Universite Laval Detection of human cysteine-rich secretory protein (crisp1) in semen and medical applications related thereto
WO2013070089A1 (en) * 2011-11-08 2013-05-16 Caldera Health Limited Method and materials for the diagnosis of prostate cancers
CN102914658A (en) * 2012-10-24 2013-02-06 高维强 Application of CRISP3 protein on diagnosis and treatment of prostate cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WEN-CHANG KO 等: "Copy number changes of CRISP3 in oral squamous cell carcinoma", 《ONCOLOGY LETTERS》, vol. 3, 31 December 2012 (2012-12-31) *
李庆伟 等: "富含半胱氨酸分泌蛋白的结构及其离子通道方面作用的研究进展", 《辽宁师范大学学报(自然科学版)》, vol. 32, no. 2, 30 June 2009 (2009-06-30) *

Also Published As

Publication number Publication date
CN103267856B (en) 2015-04-29

Similar Documents

Publication Publication Date Title
WO2014132150A1 (en) Rapid identification of organisms in bodily fluids
CN103308682A (en) Kit for rapid lip cancer diagnosis
CN101738475B (en) Hepatitis E virus antibody detection kit and preparation method thereof
CN103267863A (en) CRISP1 (cystein-rich secretory protein 1) test paper for quickly diagnosing carcinoma of maxillary sinus
CN103278644A (en) Gold-labelled CRISP (cysteine-rich secretory protein)1 kit for quickly diagnosing carcinoma of palate
CN103308695A (en) Cysteine-rich secretory protein 1 (CRISP1) kit for cheek carcinoma diagnosis
CN103308692A (en) CRISP1 (Cysteine-Rich Secretory Protein 1) gold-labeled kit for rapid oral floor carcinoma diagnosis
CN103278629A (en) Gold-labelled kit for quickly diagnosing oropharynx carcinoma
CN103293319A (en) Gold-labeled test paper for rapidly diagnosing carcinoma jaw
CN103267848A (en) CRISP1 (cystein-rich secretory protein 1) kit for quickly diagnosing gingival carcinoma
CN103308694A (en) Gold-labeled kit for salivary gland carcinoma diagnosis
CN103278645A (en) Application of gold-labelled test strip for quickly diagnosing carcinoma of lip
CN103308691B (en) Application of secretory protein 1 rich in cysteine in preparation of product for diagnosing cheilocarcinoma
CN103267856B (en) Application of kit for diagnosing jaw cancer
CN103267860B (en) Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing kit for diagnosing jawbone carcinoma
CN103267859B (en) Application of CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing gingival carcinoma
CN103293320A (en) Application of cysteine-rich secretory protein 1 (CRISP 1) in preparation of gingival cancer diagnosis products
CN103267864A (en) Application of kit for diagnosing oropharyngeal cancer
CN103267857A (en) CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing tongue cancer
CN103257228A (en) Novel application of CRISP1 (cysteine-rich secretory protein 1) kit for diagnosis on carcinoma of palate
CN103257238A (en) Application of CRISP (cysteine-rich secretory protein)1 test paper for diagnosing carcinoma of maxillary sinus
CN103267861B (en) Application of cysteine-rich secretory protein 1 in manufacturing product for diagnosing palate carcinoma
CN103257240A (en) Application of CRISP (cysteine-rich secretory protein)1 kit for diagnosing carcinoma of tongue
CN103278646A (en) Application of gold-labelled cysteine-rich secretory protein (CRISP)1 kit for diagnosing mouth floor carcinoma
CN103267862A (en) Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing gold label kit for diagnosing maxillary sinus carcinoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SHANGHAI TENTH PEOPLE'S HOSPITAL

Free format text: FORMER OWNER: SUZHOU MAERTAI NEW MATERIALS CO., LTD.

Effective date: 20150226

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 215434 SUZHOU, JIANGSU PROVINCE TO: 200072 PUTUO, SHANGHAI

TA01 Transfer of patent application right

Effective date of registration: 20150226

Address after: 200072 No. 301, Yanchang Road, Shanghai

Applicant after: Shanghai Tenth People's Hospital

Address before: 215434 room 19, business center, 730 North Ring Road, pontoon Town, Suzhou City, Jiangsu, Taicang

Applicant before: Suzhou Maertai New Material Co., Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150429

Termination date: 20190522

CF01 Termination of patent right due to non-payment of annual fee